Oxidized LDL stimulates matrix metalloproteinase-I expression in human vascular endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 11, 1999, Pages 2640-2647

  Huang, Yan ^a   Mironova, Marina ^a   Lopes Virella, Maria F ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Collagen; Endothelium; Metalloproteinases; Oxidized LDL

Indexed keywords

COLLAGENASE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ACUTE HEART INFARCTION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIPID OXIDATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; CASEINS; CELLS, CULTURED; COLLAGENASES; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIPOPROTEINS, LDL; MATRIX METALLOPROTEINASE 1; RNA, MESSENGER; SUBSTRATE SPECIFICITY; TRANS-ACTIVATION (GENETICS); UMBILICAL VEINS;

EID: 0032698709     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.11.2640     Document Type: Article

References (30)

1. Fuster V, Badimon L, Badimon J, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250, 310-318.
2. Fernandez-Ortiz A, Badimon J, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L. Characterization of the relative thrornbogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol. 1994;23:11562-1569.
3. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
4. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
5. Saren P, Welgus HG, Kovanen PT. TNF-α, and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol. 1996;157:4159-4165.
6. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-189.
7. Parthasarathy S, Rankin SM. Role of oxidized low density lipoprotein in atherogenesis. J Lipid Res. 1992;31:127-143.
8. Huang Y, Ghosh MJ, Lopes-Virella MF. Transcriptional and post-transcriptional regulation of LDL receptor gene expression in PMA-treated THP-1 cells by LDL-containing immune complexes. J Lipid Res. 1997;38:110-120.
9. Kim RS, LaBella FS. Comparison of analytical methods for monitoring auto-oxidation profiles of authentic lipids. J Lipid Res. 1987;28:1110-1117.
10. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 1989;6:67-75.
11. Cominacini L, Garbin U, Davoli A, Micciolo R, Bosello O, Gaviraghi G, Scuro LA, Pastorino AM. A simple test for predisposition of LDL oxidation based on the fluorescence development during coppercatalyzed oxidative modification. J Lipid Res. 1991;32:349-358.
12. Kawamura M, Heinecke JW, Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest. 1994;94:771-778.
13. Mushayandebvu TI, Rajabi MR. Relaxin stimulates interstitial collagenase activity in culture uterine cervical cells from nonpregnant and pregnant but not immature guinea pigs; estradial-17β restores relaxin's effect in immature cervical cells. Biol Reprod. 1995;53:1030-1037.
14. Greenberg ME, Bender TP. Identification of newly transcribed RNA. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. eds. Current Protocols in Molecular Biology. 4th ed. Brooklyn, NY: Wiley Interscience; 1993:4.10.1-4.10.9.
15. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA. Interstitial collagenase is required for angiogenesis in vitro. Dev Biol. 1994;162:499-510.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
17. Borden P, Heller RA. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Exp. 1997;7:159-178.
18. Huang Y, Hui DY. Cholesterol esterase biosynthesis in rat pancreatic AR42J cells. J Biol Chem. 1991;266:6720-6725.
19. Burleigh MC, Briggs AD, Lendon CL, Davies MJ, Born GV, Richardson PD. Collagen type I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: span-wise variations. Atherosclerosis. 1992;96:71-81.
20. Smith EB. Acid glycosaminoglycan, collagen and elastin content of normal artery, fatty streaks and plaques. Adv Exp Med. 1974;43:125-139.
21. Morton LF, Barnes MJ. Collagen polymorphism in the normal and diseased blood vessel wall: investigation of collagens types I, III and V. Atherosclerosis. 1982;42:41-51.
22. Hanson AN, Bentley JP. Quantitation of type I to type III collagen ratios in small samples of human tendon, blood vessels, and atherosclerotic plaques. Anal Biochem. 1983;130:32-40.
23. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Anerioscler Thromb. 1991;11:1223-1230.
24. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaques. Am J Pathol. 1989;135:169-175.
25. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rapture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
26. Fuster V, Lewis A. Conner Memorial Lecture: mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1994;90:2126-2146.
27. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays. 1992;14:455-463.
28. Unemori EN, Bouhana KS, Werb Z. Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. J Biol Chem. 1990;265:445-451.
29. Pepper MS, Belin D, Montesano R, Orci L, Vassalli JD. Transforming growth factor-β1 modulates basic fibroblast-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol. 1990;111:743-755.
30. Mignatti P, Tsuboi R, Robbins E, Rifkin DB. In vitro angiogenesis on the human amniotic membrane: requirement of basic fibroblast growth factor-induced proteinases. J Cell Biol. 1989;108:671-682.